Similar Stories to Lilly Weight-loss Drug Data Spurs Selloff In Sleep Apnea Stocks - Bloomberg on Bing News

Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks BloombergWhy a Pair of Eli Lilly Clinical Trials Sent ResMed Stock Tumbling InvestopediaLilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolution | Eli Lilly and Company Investors | Eli Lilly and CompanyAmid duel with Novo's Wegovy, Lilly's Zepbound homes in on potential FDA sleep apnea nod FiercePharma

BING NEWS:
  • Novo Shares Fall on Safety Data for New Weight-Loss Drug
    Shares of Novo Nordisk A/S fell after the Danish drugmaker reported mixed safety data on one of its next-generation weight-loss drugs.
    09/20/2024 - 5:15 am | View Link
  • Weight-loss drug competition heats up with growing pill market
    The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders Novo Nordisk (NVO) and Eli Lilly (LLY) by introducing GLP-1 pills. New data ...
    09/17/2024 - 10:31 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Sports News